![Qing Hai Zhao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Qing Hai Zhao
Corporate Officer/Principal at
ADAGENE INC.
Net worth: 470 941 $ as of 2026-08-30
Profile
Qing Hai Zhao is currently the Chief Manufacturing Officer at Adagene, Inc. Prior to this, he held positions as Executive Director & Head-Chemistry at NGM Biopharmaceuticals, Inc., Vice President-Manufacturing at AnaptysBio, Inc., and VP-Technical Development & Manufacturing at Forty Seven, Inc. Zhao received a doctorate degree from the University of Uppsala in 1998, an undergraduate degree from East China University of Science & Technology in 1982, and a graduate degree from Zhongshan Hospital Fudan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADAGENE, INC. 0.31% | 2026-03-17 | 167,714 ( 0.31% ) | 470 941 $ | 2026-08-30 |
Qing Hai Zhao active positions
| Companies | Position | Start |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 2020-09-30 |
Former positions of Qing Hai Zhao
| Companies | Position | End |
|---|---|---|
| FORTY SEVEN, INC. | Corporate Officer/Principal | 2020-09-30 |
| ANAPTYSBIO, INC. | Corporate Officer/Principal | 2016-12-31 |
| NGM BIOPHARMACEUTICALS, INC. | Director/Board Member | 2015-12-31 |
Training of Qing Hai Zhao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
 East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Zhongshan Hospital Fudan University
 Zhongshan Hospital Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Qing Hai Zhao
